Jason Lettmann - Feb 14, 2024 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Peter Garcia, by power of attorney
Stock symbol
ALXO
Transactions as of
Feb 14, 2024
Transactions value $
$0
Form type
4
Date filed
2/16/2024, 06:03 PM
Previous filing
Sep 12, 2023
Next filing
Mar 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALXO Common Stock Award $0 +60K +55.96% $0.00 167K Feb 14, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALXO Employee Stock Option Award $0 +190K $0.00 190K Feb 14, 2024 Common Stock 190K $15.84 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on August 14, 2024.
F2 Shares subject to the option vest in 48 equal monthly installments beginning on March 14, 2024.